<DOC>
	<DOCNO>NCT00417170</DOCNO>
	<brief_summary>The purpose study determine effect Aliskiren insulin resistance ( IR ) endothelial dysfunction ( ED ) patient high blood pressure metabolic syndrome . The efficacy Aliskiren compare Amlodipine .</brief_summary>
	<brief_title>Comparison Aliskiren Amlodipine Insulin Resistance Endothelial Dysfunction Patients With Hypertension Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : Male female adult age 18 55 year , inclusive . Sitting diastolic blood pressure ≥80 mm Hg and/or sit systolic blood pressure ≥ 130 screening . Metabolic Syndrome define Adult Treatment Panel ( ATP ) III criterion . Hypertension ( define ) impair glucose tolerance ( IGT ) impair fast glucose ( IFG ) plus one remain 3 criterion satisfy entry study . IGT IFG classify accord American Diabetes Association ( ADA ) guideline : IFG : Fasting plasma glucose 100 mg/dl ( 5.6 mmol/l ) 125 mg/dl ( 6.9 mmol/l ) IGT : Twohour plasma glucose 140 mg/dl ( 7.8 mmol/l ) 199 mg/dl ( 11.0 mmol/l ) Abnormal Positron Emission Tomography ( PET ) result baseline . ( Myocardial Blood Flow ( MBF ) less equal 35 % . ) Abnormal euglycemic clamp result baseline . ( Glucose infusion rate ( GINF ) less equal 4.2 mg/kg/min . ) Body mass index ( BMI ) less 40 . Exclusion criterion : Smokers ( use tobacco product recent past ) Cardiovascular abnormality include myocardial infarction , angina pectoris , hypertensive encephalopathy , stroke , transient ischemic attack , valvular heart disease , ventricular arrhythmia , AV block , atrial fibrillation cardiac revascularization/angioplasty past 12 month . Symptoms clinical evidence congestive heart failure know leave ventricular ejection fraction &lt; 40 % . Supine Blood pressure ≥ 160 mmHg systolic ≥110 mmHg diastolic . Clinically significant echocardiogram ( ECG ) abnormality , include history prolong QTinterval syndrome . Significant autonomic dysfunction . Severe bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . Clinically significant drug allergy , atopic allergy ( asthma , urticaria , eczematous dermatitis ) . Pregnant breastfeeding female . Premenopausal females practice nonhormonal method birth control . African Americans eligible study . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>High Blood pressure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>pre-diabetic</keyword>
	<keyword>amlodipine ,</keyword>
	<keyword>aliskiren ,</keyword>
	<keyword>IGT ,</keyword>
	<keyword>IFG ,</keyword>
	<keyword>MBF</keyword>
</DOC>